BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34477529)

  • 1. In-vitro Evaluation of Isatin Derivatives as Potent Anti-Breast Cancer Agents against MCF-7, MDA MB 231, MDA-MB 435 and MDA-MB 468 Breast Cancers Cell Lines: A Review.
    Chauhan G; Pathak DP; Ali F; Dubey P; Khasimbi S
    Anticancer Agents Med Chem; 2022; 22(10):1883-1896. PubMed ID: 34477529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds.
    Guo H; Diao QP
    Curr Top Med Chem; 2020; 20(16):1499-1503. PubMed ID: 32156238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazolyl-isatin derivatives: Synthesis, in silico studies, in vitro biological profile against breast cancer cells, mRNA expression, P-gp modulation, and interactions of Akt2 and VIM proteins.
    Freitas LAB; Sousa C; Lima BS; Duarte D; Gomes PATM; Ramos CGC; Costa VCM; Pitta MGDR; Rêgo MJBM; de Simone CA; Videira M; Leite ACL
    Chem Biol Interact; 2024 May; 394():110954. PubMed ID: 38518852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
    Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
    Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ester tethered dihydroartemisinin-3-(oxime/thiosemicarbazide)isatin hybrids as potential anti-breast cancer agents: Synthesis, in vitro cytotoxicity and structure-activity relationship.
    Liu S; Wang S; Xu D; Pan B; Chen L; Zhao S; Xu Z; Zhou W
    Drug Dev Res; 2023 Sep; 84(6):1175-1182. PubMed ID: 37165798
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Zegheb N; Boubekri C; Lanez T; Lanez E; Küçükkılınç TT; Öz E; Khennoufa A; Khamouli S; Belaidi S
    Anticancer Agents Med Chem; 2022; 22(7):1426-1437. PubMed ID: 34170810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
    Awolade P; Cele N; Ebenezer O; Kerru N; Gummidi L; Gu L; Palma G; Kaur M; Singh P
    Anticancer Agents Med Chem; 2021; 21(10):1228-1239. PubMed ID: 32990543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines.
    Badawi WA; Samir M; Fathy HM; Okda TM; Noureldin MH; Atwa GMK; AboulWafa OM
    Bioorg Chem; 2023 Sep; 138():106610. PubMed ID: 37210828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and biological evaluation of novel morpholinated isatin-quinoline hybrids as potent anti-breast cancer agents.
    Singh A; Kaur H; Arora S; Bedi PMS
    Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100368. PubMed ID: 34783073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Biological Evaluation of Novel Amyl Ester Tethered Dihydroartemisinin-Isatin Hybrids as Potent Anti-Breast Cancer Agents.
    Xu Z; Zhang X; Liu J; Zhao S; Liu J; Zhou W
    Chem Biodivers; 2023 Mar; 20(3):e202201257. PubMed ID: 36808231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Thiazolidinone/Thiazolo[3,2-
    El-Naggar M; Eldehna WM; Almahli H; Elgez A; Fares M; Elaasser MM; Abdel-Aziz HA
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29895744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
    Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM
    Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations on Anticancer Potentials by DNA Binding and Cytotoxicity Studies for Newly Synthesized and Characterized Imidazolidine and Thiazolidine-Based Isatin Derivatives.
    Arshad N; Mir MI; Perveen F; Javed A; Javaid M; Saeed A; Channar PA; Farooqi SI; Alkahtani S; Anwar J
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and in vitro cytotoxicity evaluation of novel dihydroartemisinin-isatin hybrids tethered via different length of esters as potential anti-breast cancer agents.
    Xu Z; Pan B; Chen L; Xu D
    Fitoterapia; 2023 Apr; 166():105436. PubMed ID: 36693438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Characterization, Molecular Docking, In Vitro Biological Evaluation and In Vitro Cytotoxicity Study of Novel Thiazolidine-4-One Derivatives as Anti-Breast Cancer Agents.
    Kadhim ZY; Alqaraghuli HGJ; Abd MT
    Anticancer Agents Med Chem; 2021; 21(17):2397-2406. PubMed ID: 33797379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies.
    El-Azab AS; Al-Dhfyan A; Abdel-Aziz AA; Abou-Zeid LA; Alkahtani HM; Al-Obaid AM; Al-Gendy MA
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):935-944. PubMed ID: 28718672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxifloxacin-isatin Hybrids Tethered by 1,2,3-triazole and their Anticancer Activities.
    Yang M; Liu H; Zhang Y; Wang X; Xu Z
    Curr Top Med Chem; 2020; 20(16):1461-1467. PubMed ID: 31994464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Synthesis, Derivatization and Bioactivity of Isatin: A Review.
    Chauhan G; Pathak DP; Ali F; Bhutani R; Kapoor G; Khasimbi S
    Curr Org Synth; 2021; 18(1):37-74. PubMed ID: 32972348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
    Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
    Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.